You don't need to be signed in to read BMJ Blogs, but you can register here to receive updates about other BMJ products and services via our site.

Genetic Severity Score predicts clinical phenotype in NF2

28 Aug, 17 | by hqqu

Individuals affected with Neurofibromatosis type 2 (NF2) typically develop multiple brain and spine tumours, and often lose hearing in young adulthood. The disease course can vary amongst patients and their severity is linked to genetic variations. The NF2 genetic severity score presented here, groups patients using genetic test results. The score separated patients according to 10 different outcomes, including age at diagnosis and number of interventions. This score will allow genetic information to be routinely incorporated in studies delineating the natural history of NF2, and in future studies assessing NF2 treatment response. (By Dorothy Halliday, http://jmg.bmj.com/content/early/2017/08/28/jmedgenet-2017-104519 )

 

By submitting your comment you agree to adhere to these terms and conditions
You can follow any responses to this entry through the RSS 2.0 feed.
JMG blog homepage

JMG Contact

Research developments and evidence-based medical genetics. Visit site



Creative Comms logo

Latest from Journal of Medical Genetics

Latest from Journal of Medical Genetics